Introduction {#S1}
============

Addiction presents a substantial threat to public health, with 15.3 million persons world-wide experiencing a drug use disorder ([@B45]). Substance use disorders are complex behavioral processes with varying but largely unknown molecular etiology. The self-initiated first use of drugs and progression to addiction are distinct traits that are highly heritable ([@B17]). Such heritable traits can be exploited to identify new biological mechanisms underlying the complex processes that determine addiction behavior, which, in turn, may reveal biomarkers of addiction and/or therapeutic targets for treatment. However, identifying and characterizing the specific effects of genes and variants associated with addiction behavior has been challenging due to the difficulty of modeling addiction in experimental systems ([@B13]), and the significant power requirements necessary for human genetic analysis. Genetic and genomic strategies are promising but often yield noisy data with numerous false positives and false negative results. To overcome these barriers, complex and diverse data sets can be aggregated and analyzed using advanced systems genetics approaches to discover the biological mechanisms that are associated with addiction across experimental contexts.

The locomotor activating and sensitizing effect of psycho-stimulants such as cocaine is a well-established behavioral assay for acute drug response, often assayed using the open field device. Open field testing of locomotion has been effective in high-throughput mouse phenotyping experiments to map and identify biological mechanisms underlying response to novel environments and cocaine behavioral responses ([@B46]; [@B47]). Studies in humans and non-human primates have established a relationship between cocaine sensitization with clinical symptomology ([@B5]). Cocaine-induced behavioral sensitization is a measure of drug-induced plasticity, specifically adaptation of the mesocorticolimbic dopamine (DA) system ([@B29]). Locomotion as a behavioral assay of cocaine use was employed to identify *Cyfip2* ([@B28]) via quantitative trait locus (QTL) mapping in a reduced complexity cross, as a causative variant for acute and sensitized cocaine response phenotypes. Through the use of a systems genetic analysis of cocaine self-administration in mice, *Cyfip2* has recently been associated with a homolog of a psychostimulant addiction candidate, *Fam53b* ([@B14]), the ortholog of which was initially identified in a human cocaine dependence GWAS study ([@B22]), suggesting that a common and conserved biological mechanism supports sensitization and drug use. These findings indicate that locomotor activation and sensitization to cocaine is an effective phenotypic construct to identify conserved functional genetic correlates of addiction-related behavior.

These assays have been deployed in numerous genetic studies of psychostimulant and other drugs, but efforts to identify trait-relevant genes and mechanisms in model organisms has been a lengthy process. The widespread utilization of QTL mapping and functional genomics has resulted in large numbers of QTLs, harboring numerous candidate genes, but for many of these studies, particularly hundreds of legacy studies, the challenging task of identifying the causative genes remains. In a large study using the C57BL/6J x DBA/2J recombinant inbred (BXD RI) genetic reference population and phenotype data from over 250 measures related to multiple behavioral assays across multiple batteries, [@B35] identified two QTLs (Chr 4 and Chr 15) related to locomotor activation and sensitization. Typical of many genetic analyses in two-progenitor mapping panels, these genetic loci are large and require refinement. The interval of the previously reported QTL was 20 Mbp and contained numerous protein-coding genes.

Heterogeneous functional genomic experiments can be integrated to prioritize the many genes in the interval based on diverse evidence sources. GeneWeaver^[1](#footnote1){ref-type="fn"}^, facilitates convergent analyses across multiple genomic experiments, platforms and species ([@B2], [@B1]). The GeneWeaver platform objectively integrates diverse experimental outcomes *in silico* through advanced statistical techniques to provide plausible evidence for previously unknown roles for genes involved in addiction-related behaviors. Genomic databases include published and user submitted experimental data as well as data from multiple large-scale public data resources. We have previously used GeneWeaver to identify a gene, *Ap3m2*, underlying two overlapping biological phenomena, alcohol withdrawal and alcohol preference ([@B7]), that we have validated using *Ap3m2* null mice. These and other studies (for review, [@B9]) demonstrate the effectiveness of this system to find a convergent signal in noisy functional genomics data.

In the present study, we sought to refine the large QTLs previously detected for cocaine-induced locomotor activation ([@B35]) using refined QTL analysis followed by gene prioritization using heterogeneous functional genomic studies. We prioritized positional candidates using convergent evidence from a database of publicly available genotypes, expression data, sequence variation, ontology annotations and genome-wide experiments from the addiction genomics literature to nominate the most likely candidate(s) in an interval for experimental evaluation. We identified a promising mechanistic candidate gene, *Rab3b*, and evaluated its role in cocaine-induced locomotor activation and sensitization using a gene knockout approach.

Materials and Methods {#S2}
=====================

QTL Mapping in the BXD RI {#S2.SS1}
-------------------------

Quantitative trait locus (QTL) mapping of the previously identified acute locomotor response to cocaine ([@B35]) was performed in combined male and female mice from the BXD recombinant inbred strain panel using GeneNetwork ([RRID:SCR_002388](https://scicrunch.org/resolver/RRID:SCR_002388)) ([@B44]; [@B11]; [@B35]). The original analysis of these data was based on an earlier marker map and performed a single-locus scan. To confirm the original result, and more precisely model the effect and locations of variation influencing this trait, R/QTL ([RRID:SCR_009085](https://scicrunch.org/resolver/RRID:SCR_009085)) was utilized for additional QTL model fitting ([@B6]) of multiple loci. One thousand permutations were performed for each mapping analysis to obtain genome-wide suggestive and significant thresholds. Ninety-five percent confidence intervals (CI) were obtained by extracting 1.5-LOD drop around the peak marker for statistically suggestive and/or significant QTLs.

Integrative Functional Genomic Analysis of the Candidate Genes Using GeneWeaver Database {#S2.SS2}
----------------------------------------------------------------------------------------

The candidate genes residing within the 1.5 LOD drop interval of detected QTLs were imported into GeneWeaver ([RRID:SCR_003009](https://scicrunch.org/resolver/RRID:SCR_003009)). At the time of the analysis, the GeneWeaver database contained ∼100,000 gene sets. The database consists of diverse curated gene sets. Mammalian phenotype (MPO, [RRID:SCR_004855](https://scicrunch.org/resolver/RRID:SCR_004855)) and gene ontology (GO, [RRID:SCR_006447](https://scicrunch.org/resolver/RRID:SCR_006447)) annotations and previously published QTLs were obtained from the Mouse Genome Database (MGD, [RRID:SCR_012953](https://scicrunch.org/resolver/RRID:SCR_012953)). Published gene expression studies were obtained from either the Neuroscience Information Framework ([@B21]) ([RRID:SCR_00483](https://scicrunch.org/resolver/RRID:SCR_000483)) or directly from publications. Basal gene expression from striatal and nucleus accumbens obtained from the Allen Brain Atlas ([RRID:SCR_005984](https://scicrunch.org/resolver/RRID:SCR_005984)), polymorphic genes among the BXD RI reference panel, and BXD gene expression correlates for striatal and nucleus accumbens to locomotor response after the first and second *i.p.* injection of 10 mg/kg of cocaine were generated using GeneNetwork. To find convergence of experimentally derived gene associations from genomewide experiments, the database was queried for "Cocaine, Nicotine, or Methamphetamine" followed by manual review to omit false positive search results, e.g., those for which cocaine, nicotine, or methamphetamine was mentioned in the publication abstract but was not relevant to the specific gene set. This convergent analysis resulted in the retrieval of 113 data sets.

Gene Prioritization {#S2.SS3}
-------------------

GeneWeaver's GeneSet graph tool represents the collections of gene lists as a bipartite graph, from which high-degree vertices can be identified. This structure is analyzed using the Hierarchical Similarity (HiSim) graph tool to enumerate all intersections among gene sets and highlight high order intersections containing positional candidates for prioritization of candidate genes within the two chromosomal intervals. This was performed by interrogating each of the two candidate gene lists, one from each locus, with selected gene sets describe above. HiSim was used to group experimentally derived gene-set results based on the genes they contain. For a collection of input gene sets, this tool constructs a graph of hierarchical relationships in which each terminal node represents individual gene sets and each parent node represents gene--gene set bicliques found among combinations of these sets using the maximal biclique enumeration algorithm (MBEA) ([@B49]). The resulting graph structure was determined solely from the gene-set intersections of every populated combination of gene sets. In terms of gene sets, the smallest intersections (fewest gene sets, most genes) were at the lower levels, and the largest intersections (most gene sets, fewest genes) were at the top of the graph. To prune the hierarchical similarity graph, bootstrapping was performed. The graph in the present analysis was sampled with replacement at 75% for 1,000 iterations; node-node parent-child relationships occurring in greater than 50% of the results were included in the bootstrapped graph.

Animals {#S2.SS4}
-------

Generation of mice with targeted deletions in *Rab3a; Rab3b; Rab3c*, and/or *Rab3d* function has been previously described ([@B39]). *Rab3a* heterozygous and *Rab3bcd* triple null mice were obtained from cryopreservation at The Jackson Laboratory (Strain Name: B6;129-*Rab3b^tm1Sud^ Rab3a^tm1Sud^ Rab3d^tm1Rja^ Rab3c^tm1Sud^*/J; [RRID:IMSR_JAX:006375](https://scicrunch.org/resolver/RRID:IMSR_JAX:006375)) by IVF of a B6J oocyte. The quadruple knock-out mice are lethal. The frozen sperm came from a donated mouse that had been backcrossed two or three times to C57BL/6J. The IVF pups that were homozygous wild type for *Rab3a* and heterozygous for *Rab3bcd* deletion (*Rab3bcd*^+/^*^--^*) were selected. The heterozygous mice were bred to each other to produce triple null (*Rab3bcd*^--/--^) offspring. Ninety-six mice (eight in each group) subdivided into three genotype groups \[*Rab3bcd*^+/+^(C57BL/6J), *Rab3bcd*^+/^*^--^*, - *Rab3bcd*^--/--^\] each sex and two treatments (saline or cocaine) were tested. Age- and sex-matched mice were randomly assigned to the following groups: *Rab3bcd*^+/+^ (C57BL/6J) [RRID:IMSR_JAX:000664](https://scicrunch.org/resolver/RRID:IMSR_JAX:000664)); *Rab3bcd*^+/--^; and *Rab3bcd*^--/--^. As the *−/−* mice were on a B6/129 background, the inbred *Rab3bcd*^+/+^ C57BL/6J and the *Rab3bcd*^+/--^ heterozygous mice on a mixed B6/129 background can both be considered as controls. The heterozygous mice would have a mixed background more similar to the *−/−* mice and these mice did not differ from the inbred C57BL/6J mice. The lack of a difference between the heterozygous mice and the C57BL/6J support the use of C57BL/6J as sufficient genetic controls. The mice were between 76 and 116 days of age at the start of behavioral testing. All mice were maintained at The Jackson Laboratory in climate- and 12 h light cycle-controlled rooms and provided acidified water and 5K52 chow (LabDiet/PMI Nutrition, St. Louis, MO, United States) *ad libitum*. The Jackson Laboratory Animal Care and Use Committee approved all protocols involving mice.

Behavioral Analysis {#S2.SS5}
-------------------

Prior to testing, mice were randomly assigned either to a saline (SAL) or cocaine (COCA) group. Mice were brought from their home room into the test room and allowed to habituate for 1 h. Mice were administered 10 mg/kg of saline or cocaine by *ip* injection. Immediately post-injection, mice were placed in an open field box (39 cm × 39 cm × 39 cm) and locomotor activity was recorded over 20 min using the EthoVision XT 8 ([RRID:SCR_000441](https://scicrunch.org/resolver/RRID:SCR_000441)) video tracking and analysis system (Noldus Information Technology, Wageningen, Netherlands). On days 1 and 2 of testing all mice received saline. Day 1 measurements define locomotor activity in response to injection stress and novel environment, while Day 2 measurements determine locomotor activity within a familiar environment and attenuated injection stress. On days 3, 5, 7, and 9, mice received their assigned saline or cocaine injection and the development of cocaine sensitization was measured relative to activity observed on Day 3. Tester was blind to all genotypes and treatments. Data were binned into intervals of 5 min each.

Tissue Collection {#S2.SS6}
-----------------

Whole striatal samples were collected to evaluate expression of *Cartpt*. In order to minimize differences in gene expression due to stress from handling and injection, mice were sacrificed via decapitation within 24 h of the last behavioral trial. In addition to mice that were subjected to cocaine or saline treatment, mice for behavioral testing, a behaviorally and drug naïve group of mice (*n* = 8) were also sacrificed via decapitation to obtain basal levels of *Cartpt* and housekeeping genes. Striatal tissue was collected under a dissecting scope and total striatal RNA was isolated.

qRT-PCR {#S2.SS7}
-------

Striatal tissue samples were stored in RNAlater (Life Technologies, Carlsbad, CA, United States), homogenized and total RNA was isolated by standard TRIzol^®^ Plus (Life Technologies, Carlsbad, CA, United States) methods that included DNase digestion. The quality of the isolated RNA was assessed using an Agilent 2100 Bioanalyzer instrument ([RRID:SCR_018043](https://scicrunch.org/resolver/RRID:SCR_002388)) and the RNA 6000 Nano LabChip assay. 500 ng of total RNA was then reverse transcribed with random decamers and M-MLV reverse transcriptase (RT) using the Message Sensor RT Kit (Life Technologies, Carlsbad, CA, United States).

Statistical Analysis {#S2.SS8}
--------------------

Statistical analyses were performed in JMP 9.0 ([RRID:SCR_014242](https://scicrunch.org/resolver/RRID:SCR_014242) SAS Institute Inc., Raleigh, NC, United States). To analyze the locomotor data, we performed a 3 × 2 × 2 × 6 mixed-model ANOVA using distance traveled over 20 min as the dependent measure. Between-subjects factors were *Rab3bcd* genotype (+/+, +/*−*, *−/−*), drug (saline and cocaine), and sex. Sessions (1--6) was a within-subjects factor. To dissociate the effects of *Rab3bcd* complex deletion on habituation and cocaine sensitization we performed a 3 × 2 × 2 × 6 mixed-model ANCOVA using distance traveled on session 1 and session 2 as covariates and using the same dependent measure and independent factors used in the initial ANOVA.

Results {#S3}
=======

QTL Mapping {#S3.SS1}
-----------

Locomotor activity in response to cocaine (*i.p.* injection of 10 mg/kg of cocaine) was genetically mapped to loci on Chr 4 and 15 in a previous study ([@B35]). The data from this study was remapped using software allowing for the inclusion of multiple chromosomal effects in the same model, ensuring improved accuracy of the QTL locations. The overall QTL model that best predicted locomotor response following repeated injection of cocaine (GeneNetwork Dataset GN11796; [Figure 1A](#F1){ref-type="fig"}) was a female-specific two-QTL additive model involving Chr 4 (*Cocia15 Cocaine Induced Activation 15*, rs13477919 @ 104.96 Mb) and Chr 15 (*Cocia16 Cocaine Induced Activation 16* rs13482528 @ 38.82 Mb), which together accounted for 34.28% of the trait variance ([Figure 1B](#F1){ref-type="fig"}). A 1.5 LOD window was used to define the 95% confidence interval (CI). The Chr 4 CI spans 101.10 (rs13477873) -- 114.51 (gnf04.110.583) Mb ([Figure 1C](#F1){ref-type="fig"}) while the Chr 15 CI spans 33.43 (rs8267966) -- 45.11 (rs13482547) Mb ([Figure 1D](#F1){ref-type="fig"}). The Chr 4 and Chr 15 QTLs accounted for 11.38 and 15.60% of the trait variance, respectively. Furthermore, at each of these loci the DBA2/J (D2) allele is the increaser allele ([Supplementary Figures S1A,B](#PS1){ref-type="supplementary-material"}). No significant interactions among these loci were detected. A genome-wide pair scan was also performed, resulting in the detection of a significant Chr 4 (rs13477881 @ 103.31) × Chr 5 (rs3723202 @ 91.57) interaction ([Supplementary Figure S1C](#PS1){ref-type="supplementary-material"}, *p* \< 0.001). Inclusion of this interaction term increases the percent variance accounted for by the model to 55.40%. Positional candidate genes underlying each of these regions were retrieved from the Mouse Genome Informatics (MGI) database^[2](#footnote2){ref-type="fn"}^ ([@B18])\]. Each gene list was uploaded to [GeneWeaver.org](https://www.geneweaver.org/) ([@B1]) for integrative functional genomic analysis.

![Quantitative trait locus (QTL) mapping of cocaine response in the expanded BXD RI genetic reference population: QTL mapping of locomotor response following the second injection of cocaine in females resulted in the detection of suggestive QTLs on Chr 4 and Chr 15. **(A)** Green lines indicate regions where DBA/2J is associated with increased phenotypic effect the increaser allele, red lines indicate that C57BL/6J is associated with the increased phenotypic effect. **(B)** The two QTL additive model involving Chr 4 and Chr 15. Additive the black horizontal lines represent the 1.5 LOD support interval on Chr 4 **(C)** and Chr 15 **(D)**. The LOD support interval on Chr 4 spans 101.10 (rs13477873) 114.51 (gnf04.110.583) Mb, while on Chr 15 it spans 33.43 (rs8267966) 45.11 (rs13482547) Mb. 108 and 61 positional protein coding candidate genes reside in the Chr 4 and Chr 15 intervals, respectively.](fnins-14-00721-g001){#F1}

Integrative Functional Genomic Analysis of the Candidate Genes Reveals *Rab3b* as a Likely Candidate Gene for Locomotor Response to Cocaine {#S3.SS2}
-------------------------------------------------------------------------------------------------------------------------------------------

A search of keywords pertaining to cocaine, methamphetamine, heroin and nicotine was performed in GeneWeaver \[05-01-2012\] and 3,315 sets were retrieved ([@B34]). This was followed by a closer inspection of the descriptive meta-content associated with the search results, and removal of redundant or misidentified gene sets (e.g., abstract referenced cocaine, gene set was from untreated controls). A total of 113 gene sets with an average of 66.5 genes per gene set and spanning 19 publications ([Figure 2A](#F2){ref-type="fig"} and [Supplementary Table S1](#TS1){ref-type="supplementary-material"}) were retained for analysis. The HiSim analysis tool was used to construct an empirically derived hierarchy of the input gene sets for both the Chr 4 and Chr 15 candidate gene list. This allowed us to identify the most highly connected positional candidate genes among a large number of genomic data sets, suggesting that it is the one most frequently implicated in functionally relevant studies. The gene with the highest degree (7) of connectivity from either the Chr 4 ([Figure 2B](#F2){ref-type="fig"}) or Chr 15 positional candidates was *Rab3b* (Chr 4 108.87--108.94 MBp): a member of the RAS oncogene family thought to function in protein metabolism and cell junction dynamics ([@B40]; [@B41]). *Rab3b* is expressed in the dorsal and ventral striatum, down-regulated in C57BL/6J and up-regulated in C3H/HeJ after exposure to another psychostimulant, nicotine GS:14888 ([@B43]), and is differentially expressed in dopamine receptor 1 mutants when compared to their wild-type controls after saline treatment GS:87050 ([@B48]). Furthermore, *Rab3b* is a candidate gene for three previously published QTLs, all of which were mapped in the BXD RI reference population, derived from the inbred progeny of a cross of the C57BL/6J and DBA/2 strains. These three traits mapped to *Rab3b* were climbing behaviors in response to methamphetamine GS:84160 ([@B23]), repeated movements following cocaine GS:84158 ([@B26]) and hypothalamic CART peptide (*Carpt*) abundance GS:83998 ([@B4]). In each of the three QTLs, the DBA/2-derived allele increases activity and peptide release, which also occurs as the allelic effect of the cocaine response QTL on Chr 4 (*Cocia15*).

![Integrative functional analysis in GeneWeaver. **(A)** Hierarchical Similarity tool depicting a hierarchical representation of gene sets used in the integrative analysis. Nodes at the top are highly connected genes. Pink colored nodes represent nodes containing one or more QTL candidate genes. Rab3b is revealed as the most highly connected QTL candidate gene. **(B)** GeneSet graph representing the underlying interconnections among the gene sets containing Rab3b.](fnins-14-00721-g002){#F2}

To evaluate this candidate experimentally, *Rab3b* targeted mice were characterized for cocaine response. We did not observe any locomotor, cocaine or habituation difference in the Rab3b KO ([Supplementary Figure S2](#PS1){ref-type="supplementary-material"}). Previous studies have suggested that compensatory effects of Rab complex proteins limit the effect of individual gene deletions ([@B39]; [@B42]), thus a triple knock-out approach was necessary to effectively inactivate this functionality. Accordingly, *Rab3b*, *Rab3c* and *Rab3d* (B6;129-*Rab3b^tm1Sud^ Rab3c^tm1sud^ Rab3d^tm1sud^*) ([@B39]; [@B42]) was obtained from The Jackson Laboratory for experiments.

Assessment of Cocaine Response in *Rab3bcd* Triple Null Mice {#S3.SS3}
------------------------------------------------------------

A 9 days cocaine sensitization paradigm modeled after the work of [@B36] was administered. Briefly, on days 1 and 2 of testing, all mice received saline. Day 1 measurements define locomotor activity in response to injection stress and novel environment, while Day 2 measurements depict locomotor activity within a familiar environment (habituation) and attenuated injection stress. On Days 3, 5, 7, and 9, mice received their assigned saline or cocaine injection *i.p.*, blinded to investigator.

There were significant main effects of genotype \[*F*~(2,83)~ = 10.68, *p* \< 0.0001\], drug \[*F*~(1,83)~ = 194.69, *p* \< 0.0001\], and session \[*F*~(5,79)~ = 101.31, *p* \< 0.0001\], as well as a significant three-way interactions among these factors \[*F*~(10,158)~ = 1.98, *p* = 0.03\]. To determine the nature of the three-way interaction, we examined performance of each of the genotype-drug subgroups on all sessions ([Figures 3A--C](#F3){ref-type="fig"}). *Rab3bcd−/−* mutants exhibited significantly greater cocaine activation (*p* \< 0.05) relative to wild type and heterozygote mice on all but the second cocaine session ([Figure 3B](#F3){ref-type="fig"}). However, *Rab3bcd−/−* mutants also traveled a significantly greater distance relative to wild type and heterozygote mice on several sessions in the saline condition beginning with the first saline injection ([Figure 3C](#F3){ref-type="fig"}), suggesting an effect of *Rab3bcd* complex perturbation on habituation to a novel environment.

![Cocaine induced locomotor activation in Rab3bcd mutants, heterozygotes, and wild types. **(A)** Rab3bcd*--/--* mutants exhibited significantly greater cocaine sensitization (*p* \< 0.05) relative to wild types and heterozygotes on all but the second cocaine session **(B)**. However, Rab3bcd*--/--* mutants also traveled a significantly greater distance relative to wild types and heterozygotes on several sessions in the saline condition beginning with the first saline injection **(C)**, suggesting an effect of Rab3bcd on habituation to the apparatus or injection stress. After adjusting for the effect of habituation **(D--F)** by including distance traveled on the first two sessions as covariates, the significant effect of Rab3bcd on cocaine sensitization persisted, whereas significant differences in distance traveled between wild types, heterozygotes, and mutants in the saline condition were no longer observed. These data indicate significant effects of Rab3bcd on both habituation and cocaine sensitization. \**p* \< 0.05.](fnins-14-00721-g003){#F3}

To dissociate the effects of *Rab3b* manipulation on habituation and cocaine sensitization, we performed a 3 × 2 × 2 × 6 mixed-model ANCOVA using distance traveled on session 1 and session 2 as covariates ([Figures 3D--F](#F3){ref-type="fig"}). The main effects of genotype \[*F*~(2,81)~ = 3.69, *p* = 0.02\], drug \[*F*~(1,81)~ = 355.83, *p* \< 0.0001\], and session \[*F*~(4,\ 78)~ = 6.04, *p* = 0.0003\], as well as the three-way interaction between these factors \[*F*~(8,156)~ = 2.24, *p* = 0.02\] remained significant. *Post hoc* tests indicated that after adjusting for the effects of habituation, effects of *Rab3b* on cocaine activation persisted ([Figure 3E](#F3){ref-type="fig"}), whereas the previously significant differences in distance traveled between wild types, heterozygote, and mutant mice were no longer observed ([Figure 3F](#F3){ref-type="fig"}).

Cartpt Transcript Abundance in Rab3bcd*^--/--^* and C57BL/6J {#S3.SS4}
------------------------------------------------------------

The GeneWeaver search revealed a previously published QTL mapping study involving cocaine- and amphetamine-regulated transcript peptide transcript abundance ([@B4]) and the *Cocia15* QTL. *Cartpt* is involved in reward- and feeding-related behaviors. Studies in rats have shown that CART mRNA expression after acute cocaine self-administration is upregulated in brain regions of the mesocorticolimbic dopamine system ([@B16]). To assess the effects of *Rab3bcd* variation on *Cartpt* expression, we analyzed *Cartpt* expression using Δ*C*~t~ values to detect genotype (*Rab3bcd*^--/--^ and C57BL/6J) × treatment (naïve, SAL and COCA) effects. The genotype x treatment effect was suggestive \[*F*~(2,2)~ = 2.58; *p*~genotype\ ×\ treatment~ \< 0.08\] ([Table 1](#T1){ref-type="table"}). No significant differences were observed across genotypes for the naïve group, suggesting that *Rab3bcd* deletion had no effect on expression of *Cartpt.* However, planned contrasts revealed differences in *Cartpt* expression following saline or cocaine treatment. Following saline or cocaine treatment *Cartpt* is differentially expressed across the two genotypes \[SAL: *F*~(1,42)~ = 10.03, *p*~genotype~ \< 0.003; COCA: *F*~(1,42)~ = 11.10, *p*~genotype~ \< 0.002\]. Within genotype contrasts failed to detect any significant differences across the two treatments \[*Rab3bcd*^--/--^: *F*~(1,42)~ = 1.76, *p*~treatment~ \< 0.19; C57BL/6J: *F*~(1,42)~ = 1.84, *p*~treatment~ \< 0.18\] ([Table 2](#T1){ref-type="table"}). These results suggest that disruption of the Rab3 complex induces dysregulation of *Cartpt* in response to injection of either saline or cocaine.

###### 

*Cartpt* ΔΔ*C*t values for C57BL/6J and *Rab3bcd−/−* among naïve, saline, and cocaine treated mice.

            **Δ *C*t -- Mean ± SE**   
  --------- ------------------------- --------------
  Naïve     10.24 ± 0.19              10.12 ± 0.23
  Saline    10.55 ± 0.11              9.75 ± 0.15
  Cocaine   10.22 ± 0.16              9.42 ± 0.18

Gapdh was used in the calculations of ΔCt.

###### 

*Cartpt* Δ*C*t values for C57BL/6J and *Rab3bcd−*/*−* among naïve and challenged (saline and cocaine treated) mice.

              **Δ *C*t -- Mean ± SE**   
  ----------- ------------------------- --------------
  Naïve       10.24 ± 0.19              10.12 ± 0.23
  Treatment   10.36 ± 0.11              9.58 ± 0.11

Gapdh was used in the calculations of ΔCt.

Discussion {#S4}
==========

Here we present the discovery of a role for the *RAB3B* complex in habituation and cocaine-induced activation using the GeneWeaver integrative functional genomic analysis of the candidate genes for a previously mapped cocaine-induced activation QTL within the BXD RI genetic reference population ([@B35]). We have shown that by incorporating multiple independent lines of evidence from convergent studies it is possible to readily interrogate a QTL interval, to arrive at highly likely candidate genes. In the integrative functional genomic analysis described in this report, we have incorporated empirical information derived from 21 published studies. The approach is relatively unbiased in that the genome-wide studies integrated into the analysis evaluate virtually all positional candidates in the QTL interval. Using these genomic data sets, we have identified a highly likely gene, *Rab3b*, which resides in the *Cocia15* QTL. RAB proteins belong to the family of Ras-like GTPases, and are primarily involved in trafficking of secretory and endocytic vesicles in eukaryotic cells ([@B32]; [@B30]). Sixty known RAB proteins exist, with the RAB3 subfamily being the most abundant and expressed at variable levels in the brain ([@B40]; [@B41]; [@B24]). The RAB3 protein subfamily consists of four homologous isoforms, namely, RAB3A, 3B, 3C, and 3D. RAB3A, 3B and 3C co-localize on presynaptic vesicles, while RAB3D localizes to secretory vesicles in exocrine glands ([@B20]; [@B31]; [@B38]). The RAB3 subfamily is involved in regulated exocytosis and in docking, priming and fusion stages of the synaptic vesicle cycle. Specifically, *in vitro* studies have revealed that RAB3 proteins inhibit Ca^2+^-triggered exocytosis in PC12 cells ([@B38]). *Rab3b* is expressed in neurons but not astrocytes or oligodendrocytes ([@B10]). The integrative functional genomic evidence presented here from multiple independent studies has suggested variation in the RAB3B subunit as a source of phenotypic variation of multiple traits but deletion of this gene is likely developmentally compensated by other subunits due to functional redundancy, with *RAB3A* minimally needed for survival ([@B39]; [@B12]). Because of this functional redundancy among RAB3 members, a triple knock-out approach was necessary to effectively inactivate this functionality. Of these genes only *Rab3b* resides in the QTL interval on Chr 4. Our *Cocia15* QTL for cocaine response harboring *Rab3b*, has also been detected in three previous BXD mapping studies, namely, CART (*Carpt*) transcript abundance ([@B4]), methamphetamine-related climbing behavior ([@B23]) and cocaine-related behavior (repeated movements at 5 mg/kg) ([@B26]). *Rab3b* is expressed in the striatum, nucleus accumbens and the ventral tegmental area of mice^[3](#footnote3){ref-type="fn"}^, all of which are addiction-relevant regions of the brain. Each of these brain regions contains dopaminergic neurons and plays a central role in cocaine-mediated behaviors. *In vitro* and *in vivo* studies involving overexpression of *Rab3b* in dopamine neurons of the rat substantia nigra (SN) has revealed that overexpression of *Rab3b* increases dopamine content, uptake, number and size of synaptic vesicles, and levels of presynaptic proteins ([@B12]). The role of *Rab3b* in Ca^2+^-triggered exocytosis, localization on synaptic vesicles, expression in addiction-relevant tissues and appearance in multiple independent QTL mapping studies that target the dopaminergic system makes it a highly likely candidate gene underlying the cocaine-induced locomotor response QTL.

The effects of RAB complex manipulation on habituation to the open field, behavioral response to repeated cocaine injection, and the effects on CART expression which are induced by either saline or cocaine injection suggest that the complex is involved in response to salient or novel experiences, and the potential reinforcement of exposure to certain novel experiences. This is supported by the same locus on Chr 4 being identified when the saline controls were mapped in the original dataset ([@B35]). A significant literature supports the hypothesis that exposure to novelty and sensory stimuli are reinforcing across species reviewed in [@B25]. Moreover, multiple studies reveal the predictive relationship of novelty seeking and sensation seeking on drug use and effect ([@B37]; [@B3]; [@B15], [@B14]). The present findings provide causal evidence that the RAB complex is part of a larger network underlying these associations.

At the Chr 4 QTL, the C57BL/6 allele is associated with lower activity and response to cocaine than the DBA/2 allele. Without baseline expression differences, it is difficult to predict the direction of effect in a knock-out on a C57BL/6J background. However, multiple genetic factors can impact the direction of the effects of the mutation on behavior including the interactions of the complex proteins, the interactions of genetic background and the mutations effects on other interacting mechanisms. Therefore, our experimental validation is limited to a confirmation of the involvement of Rab3 complex in this behavior, and specifically of Rab3b due to the QTL mapping result. Future work could refine this by identifying and modeling the precise allelic variant involved in Rab3b abundance or function.

The putative mechanism of genetic variation in the mouse can ultimately be discerned from the location of the variants affecting *Rab3b*. The SNPs that exist in *Rab3b* between C57BL/6 and DBA/2 founders of the BXD RI strains are either intronic or 5′ and 3′ intergenic. The Sanger re-sequencing project, using heterogeneous stock QTL mapping results, has shown that functional variants at small effect QTLs (\<4%) are most likely to be intergenic, and that functional variants at large effect QTLs (\>4%) are most likely to be intronic ([@B27]). *Cocia15* QTL harboring *Rab3b* is a large effect QTL accounting for 11.38% of the trait variation. There is no *cis*-eQTL for *Rab3b* detected in the BXD RI panels including using RNA-seq data sets and exome microarrays^[4](#footnote4){ref-type="fn"}^ (not shown). We tested for differential splicing of the Rab3b-L (OTTMUST00000018722) and Rab3b-S (OTTMUST00000018724) transcripts, and detected no alternate splicing between the drug naive founders (data not shown). The absence of a detectable *Rab3b* eQTL does not preclude genomic variation in expression regulation. One potential explanatory SNP that exists in B6 vs. D2 is at rs32262045. Importantly this SNP lies within a region of *Rab3b* known to display cocaine-induced epigenetic changes in 5-hydroxymethylcytosine (5hmC) ([@B19]). These types of cocaine-induced DNA methylation changes in genomic regions are correlated with changes in local gene expression. Another promising causal variant is SNP rs32532179 which lies within a LINE/L1 (Long interspersed nuclear element) element of 738 bp LINE ([@B33]). Repetitive elements, in particular LINE1 have recently been shown to be subject to activation or epigenetic regulation through H3K9Me3. These SNPs leave open the possibility that an epigenetic mechanism; with complex developmental and spatial regulation underlies the behavioral phenotype; likely due to exposure to some other environmental factor earlier on. GeneNetwork captures many brain regions but we know it is not exhaustive. Further, the altered differential expression of *Rab3b* during embryogenesis due to B6/D2 allelic variation can produce the observed phenotypic differences. This would be consistent with the known embryonic lethality of the Rab3 quadruple mutant (B6;129-*Rab3b^tm1Sud^ Rab3a^tm1Sud^ Rab3d^tm1Rja^ Rab3c^tm1Sud^*/J). Engineering of these variants in cellular and mouse experiments can provide conclusive experimental identification of the regulatory variant, and how it responds to repeated experience.

In summary, our findings demonstrate the use of integrative functional genomics as a tool to identify a novel biological mechanism of cocaine-induced locomotor activation, habituation and other effects of exposure. Using the integrative functional genomic analysis we identified and validated of *Rab3b* as a candidate gene for cocaine-induced locomotor activation based on genetic and functional evidence. Future studies into this mechanism may elucidate its precise role in the response to novel stimuli. Further application of the integrative functional genomics approach may enable discovery of mechanism of other complex trait variation from aggregate data from current and legacy genetics and genomics.
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